The Acusera range of Diabetes controls provide a true third-party solution for key tests used in the diagnosis and monitoring of diabetes and haemoglobin variants. Designed for use on multiple platforms, an independent assessment of analytical performance is guaranteed.
An extended reconstituted stability of four weeks for many controls will not only keep waste to a minimum but will help reduce costs. As with all Acusera controls, laboratories can expect to experience reduced time and costs without compromising on consistency or quality.
To find out more about the Acusera Diabetes and Whole Blood Controls or to get in touch with your local Randox Representative, enquire now.
Clinically Relevant Levels
Analytes at medical decision levels, ensuring accurate instrument performance and patient results.
Unrivalled Stability
A longer working stability minimises waste material and reduces overall volume of QC required.
Assayed Target Values
Highly accurate, robust target values for a range of instruments and methods.